2-144141942-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001376312.2(GTDC1):c.461G>A(p.Ser154Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000182 in 1,611,488 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001376312.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTDC1 | NM_001376312.2 | c.461G>A | p.Ser154Asn | missense_variant | 6/12 | ENST00000682281.1 | NP_001363241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTDC1 | ENST00000682281.1 | c.461G>A | p.Ser154Asn | missense_variant | 6/12 | NM_001376312.2 | ENSP00000507713 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151950Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000678 AC: 17AN: 250594Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135408
GnomAD4 exome AF: 0.000190 AC: 277AN: 1459538Hom.: 1 Cov.: 29 AF XY: 0.000207 AC XY: 150AN XY: 726098
GnomAD4 genome AF: 0.000105 AC: 16AN: 151950Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74218
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The c.461G>A (p.S154N) alteration is located in exon 6 (coding exon 3) of the GTDC1 gene. This alteration results from a G to A substitution at nucleotide position 461, causing the serine (S) at amino acid position 154 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at